United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Technology Industry News Accenture enhances private equity offerings with acquisition of Impendi Accenture (NYSE: ACN) has strategically broadened its service offerings for the private equity industry by acquiring Impendi, a… byPallavi MadhirajuJanuary 19, 2024